A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder
Clinical trial NCT04155424 · TERMINATED
Trial details
- NCT number
- NCT04155424
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-14
- Primary completion
- 2023-07-31
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.